Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Shi, Xiao-Pinga; * | Tugusheva, Katherinea | Bruce, James E.b | Lucka, Adama | Chen-Dodson, Elizabetha | Hu, Binghuaa | Wu, Guo-Xina | Price, Erica | Register, Robert B.a | Lineberger, Janeta | Miller, Rona | Tang, Mei-Jya | Espeseth, Amya | Kahana, Jasona | Wolfe, Abigaila | Crouthamel, Ming-Chiha | Sankaranarayanan, Sethua | Simon, Adama | Chen, Lina | Lai, Ming-Taina | Pietrak, Betha | DiMuzio, Jilliana | Li, Yuemingc | Xu, Mina | Huang, Qiana | Garsky, Victord | Sardana, Mohinder K.a | Hazuda, Daria J.a
Affiliations: [a] Department of Biological Chemistry, Merck Research Laboratories, West Point, PA 19486, USA | [b] Department of Chemistry, Washington State University, Pullman, WA 99164-4630, USA | [c] RRL-617A, Box 459, Memorial Sloan-Kettering Cancer Center, 1275, York Ave., New York, NY 10021, USA | [d] Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA
Correspondence: [*] Corresponding author: Xiao-Ping Shi, WP16-205, Department of Biological Chemistry, Merck Research Laboratories, West Point, PA 19486, USA. Tel.: +1 215 652 3622; Fax: +1 215 652 0264; E-mail: xiao-ping_shi@merck.com.
Note: [] Communicated by Yuan Luo.
Abstract: Abnormal production and accumulation of amyloid-β peptide (Aβ) plays a major role in the pathogenesis of Alzheimer's disease (AD). β-secretase (BACE1) is responsible for the cleavage at the β-site in amyloid β protein precursor (AβPP/APP) to generate the N-terminus of Aβ. Here we report the stepwise identification and characterization of a novel APP-β-site mutant, “NFEV” (APP_NFEV) in vitro and in cells. In vitro, the APP_NFEV exhibits 100-fold enhanced cleavage rate relative to the “wild-type” substrate (APPwt) and 10-fold increase relative to the Swedish-type mutation variant (APPsw). In cells, it was preferably cleaved among 24 APP β-site mutations tested. More importantly, the APP_NFEV mutant failed to generate any detectable Aβ peptides in BACE1-KO mouse fibroblast cells. The production of Aβ peptides was restored by co-transfecting human BACE1, demonstrating that BACE1 is the only enzyme responsible for the processing of APP_NFEV in these cells. Analysis of APP_NFEV cleavage products secreted in the media revealed that in cells BACE1 cleaves APP_NFEV at the position between NF and EV, identical to that observed in vitro. A BACE inhibitor blocked the processing of the APP_NFEV β-site in vitro and in cells. Our data indicates that the "NFEV" mutant is not only an enhanced substrate for BACE1 in vitro, but also a specific substrate for BACE1 in cells.
Keywords: Alzheimer's disease, BACE, β-secretases, APP
DOI: 10.3233/JAD-2005-7207
Journal: Journal of Alzheimer's Disease, vol. 7, no. 2, pp. 139-148, 2005
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl